Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: J Heart Lung Transplant. 2009 Oct;28(10):1050–1056. doi: 10.1016/j.healun.2009.04.032

Figure 2.

Figure 2

Outcome including any CMV episodes, death or retransplantation, or no events before one year post-transplant categorized by the receipt of CMVIG and type of CMV episode. Reported as percentages of the total in each group A: CMV infection (excluding those with CMV disease without prior infection) (CMVIG n=49; no CMVIG n=220) B: CMV disease (CMVIG n=62, no CMVIG n=267)